BACKGROUND
Measles is a highly contagious disease that infected almost all vulnerable populations during the pre-vaccination era, with the case fatality rate ranging 3%-15% in the developing countries (1) . The transmission occurs through droplets or aerosols and results in secondary attack rate of more than 70%-80% in susceptible populations (2) . Measles is potentially eradicable because humans are the only reservoir to the virus, a sensitive and specific diagnostic tool is available, and an effective vaccine is available (3) .
The vaccines play a key role in the elimination of measles. It is estimated that one dose of measles vaccine confers at least 95% effectiveness in preventing clinical measles and 92% effectiveness in preventing secondary cases among household contacts (4) . The highly transmissible measles records basic reproduction number of greater than 10, therefore the vaccination coverage of more than 95% is necessary to achieve effective herd protection from the vaccines (5) . Current strategies for the global eradication of measles include achieving high vaccination coverage coupled with epidemiological and laboratory surveillance. The two-dose measles vaccination program is now being recommended globally, however, the implementation is challenging in countries with limited health resources. The weak health systems hinder the key components in routine vaccination services: stable vaccine procurement, maintenance of coldchain, and effective vaccination delivery. To overcome these challenges, various vaccination strategies have played a role for attaining adequate vaccination coverage and stopping endemic transmission of the measles virus in the community (6, 7) .
In the World Health Organization (WHO) Western Pacific Region Office (WPR), substantial progress has been made to control and interrupt measles transmission (8) . However, the measles virus continues to circulate causing outbreaks in the WPR countries, potentially due to limited success in achieving universally high vaccination rates at the sub-national level. In this report, we aimed to provide perspectives in measles elimination, with sharing the experiences from the Republic of Korea, to intensify efforts to close gaps in population immunity of measles with the WPR member states and regions.
GLOBAL MEASLES ELIMINATION ACTIVITIES
The measles-containing vaccines (MCV) have been used routinely in many countries, employing different schedules and doses for nearly 50 yr. Strengthening of the measles vaccination activities dates back to the 1974, when the WHO has initiated the Expanded Program on Vaccination (EPI), aiming to develop and support the increase of vaccination coverage (9) . However, the global vaccination coverage in the 1980s was low, less than 60%, and consequently measles continued to prevail causing more than 2 million cases per year. In the late 1980s, following the World Health Assembly's resolution to reduce measles morbidity by 90% and mortality by 95% and the World Summit for Children's implementation to target vaccination coverage among 90% of children, the measles cases decreased to 1-1.5 million annual cases in the 1990s (10) . In 2000, the WHO and the United Nations Children's Fund (UNICEF) have recommended the two doses of measles vaccine (MCV2) in every child. Globally, the achievement of high vaccination coverage of the first and second doses of MCV has led to dramatic decrease in the measles incidence (Fig. 1) .
However, concerns have been raised over the apparent discrepancies between coverage rates in the WHO Regions. The Regions of Americas and Europe, with their steady increase in the vaccination coverage since 1980, have reached MCV1 coverage of more than 90% in the 1990s, and sustained low incidence of measles in the 2000s (Fig. 2) . The increase in MCV1 coverage in Regions of Eastern Mediterranean and Western Pacific were noted in 1980s, but less than 90% coverage in the 1990s led to ongoing transmission of the virus in their Regions. In the Regions of Africa and Southeast Asia, there were significant reduction in overall incidence rates; however, the Region's most remote and hard-to-reach population are still vulnerable to transmission and outbreak of measles due to poor access to vaccines.
ELIMINATION OF MEASLES IN THE REGION OF AMERICAS
In 2002, the Region of Americas became the first WHO region to interrupt measles transmission, and several lessons have been learned from their experiences. Innovative measles vaccination strategies were implemented in the Region since 1990s. The strategies aimed to rapidly interrupt the measles transmission by performing mass vaccination campaigns, namely "catch-up", "mop-up", and "follow-up", and to maintain high population immunity by providing adequate vaccination coverage to each successive birth cohorts through routine vaccination services (11) . The "catch-up" vaccination campaign is a one-time mass vaccination campaign conducted for a defined age group (usually children aged 9 months to 14 yr). After the "catch-up" campaign was conducted, there were portions of the population with inadequate vaccination coverage; therefore a "mop-up" campaign was conducted to increase vaccination in areas of low coverage. Because the vaccine is not 100% effective and the measles virus is highly transmissible, the accumulation of susceptible population over time may result in on-going transmission of the virus; therefore, a "follow-up" vaccination campaign was conducted every 2-5 yr periodically to increase the population immunity.
Between 1989 and 1995, a total of 39 out of 41 countries in the Region of Americas have conducted catch-up campaigns and periodic follow-up campaigns every four years (12) . All children aged 9 months to 14 yr, irrespective of previous vaccination history, have been vaccinated within a short period of time. Since there may still remain pockets of population with limited access to catch-up campaign, the special vaccination or mopup campaign were carried out in areas to increase their level of immunity. The catch-up and mop-up campaigns resulted in a rapid increase in population immunity, and contributed in overall reduction of measles incidence in the Region. After the initial catch-up campaign, strengthening of routine vaccination services to "keep-up" at least 95% of each birth cohorts at 12-15 months of age was conducted. And to ensure the adequate herd immunity among children, the "follow-up" vaccination campaigns had been conducted. These vaccination strategies were accompanied by the improvements in virologic and epidemiologic surveillance schemes.
The implementation of the vaccination strategies in the Region of Americas has resulted in reduction of measles incidence as depicted in Between the three periods, the incidence rates in the Region of Americas have decreased by 90% and 99%, respectively (Fig. 2 , Table 1 ).
WESTERN PACIFIC REGION AND THE ELIMINATION GAP
Since the 1960s, many countries and areas of the WPR have included MCVs as a part of their routine vaccination program (13, 14) . By 1990s, all member states have included measles vaccine, usually in the form of monovalent vaccine, and in Guam, Hong Kong, Palau, and Singapore, it is given in the form of measlesmumps-rubella (MMR) vaccine. MCV2 was first implemented in American Samoa, New Zealand, Palau, and Samoa. As the poliomyelitis eradication activities have led to strengthening of routine immunization system, it also contributed to increase of measles vaccination coverage in Cambodia, China, Lao PDR, the Philippines, and Vietnam (15) . During the national immunization days for poliomyelitis eradication in the Philippines, supplementary measles and tetanus toxoid vaccines were also given to all children between 9 and 59 months of age (16) . By 2003, the introduction of measles immunization programs in WPR countries has resulted in dramatic decreases in morbidity and mortality attributable to measles. In Pacific islands, Australia, Mongolia, and Korea, experiences indicate that elimination can be achieved in countries with diverse geography, populations, and measles epidemiology (13) . Between 1980 and 1991, the estimated annual incidence in the WPR was 628,878 cases, which accounted for 22.5% of the global incidence ( Table 1) Although the countries and areas in the WPR experience an overall decrease in burden of measles, there were large numbers of cases continue in several countries. The WHO-led intensified vaccination efforts focused on Cambodia, Laos, Papua New Guinea, and Vietnam at first, yet, China and Japan, the most populous two countries accounting 80% of the region's population, were not included (19) . In 2008, a total of 131,441 measles cases (98.4 per million population) were reported from China and 11,015 cases (86.1 per million population) from Japan (20) . In China, although the incidence of measles decreased from 9.95 in 2008 to 0.46 in 2012, however increased in 2013 by 1.96, potentially due to immunity gaps between birth cohorts (21) . In Japan, the regular vaccination schedule has been changed to two-dose schedule since 2006, however there were still estimated 5-10 thousands measles cases and 50 measles death annually (22) . The outbreaks were also reported in distant countries: (27) . The investigation revealed that 35% of cases between 6 months to 5 yr did not receive a MCV1 in routine immunization. 
EXPERIENCE IN THE REPUBLIC OF KOREA
In the Republic of Korea, the annual number of notified cases has declined after the introduction of MCV in 1965, and further down to 1,000-1,800. The MCV1 was included in the National Immunization Program (NIP) in 1985, and MCV2 became recommended by Korean Society of Pediatrics since 1997 ( (30) . In 2000, the estimated MCV1 and MCV2 coverages were 86.2% and 37.7% respectively among 14,032 children selected for national survey (31) . Therefore, a strong mandatory MCV2 vaccination among children such as entering elementary school became in need. The early system involved passive reporting from doctors to issue certificate of MCV2 vaccination to the parents or guardians and demonstrated adequate validity. In a survey of doctors, 59.5% of the certificates depended on the medical records of clinic, 13.5% was immunization booklets, 23.7% was re-immunizations, 1.9% was confirmation of record of other clinics, and 1.4% was parents' statements or requests without evidence (32) . A randomized survey in 2010 revealed an increase of vaccination coverage of 98.3% for MCV1 and 66.1% for MCV2 (33) . The recent introduction of electronic registry of all vaccination records in Korea may further improve the MCV2 coverage and validity of the coverage data (34) .
The routine surveillance of measles in Korea involves a passive reporting of clinically diagnosed cases. The case-based surveillance with laboratory confirmation should be conducted in all patients with fever, measles-like rash and one of cough, coryza and conjunctivitis, and the collection of serum and throat swab specimens became mandatory. In 2006, the active laboratory-based surveillance was established, which involved mandatory reports from sentinel laboratories to the Korea Centers for Disease Control and Prevention (KCDC) (35) . When the KC-DC receives direct notification from sentinel laboratories, the investigation team immediately starts an investigation of each case. To enhance the human resource capacities of immunization, the Field Management Training Program (FMTP) was established to train annually the health workers of more than 250 public health centers located across the country.
After implementation and improvement of the program, a number of annual reported cases have declined to less than one case per million persons, and Korea became the first nation in Western Pacific to declare the elimination in 2006. Between 2002 and 2005, a decrease in measles incidence was noted, whereas cyclical increases were noted from 2006 to 2011. Most cases were in the age groups 0-23 months and 12-17 yr (36). The two unexpected outbreaks of measles that occurred during 2006 in a kindergarten in Incheon, and during 2007 in which cases that were mostly nosocomial transmission (37, 38) . In 2010, an outbreak occurred in a junior high school that included 74 vaccine-modified measles cases with limited symptoms that resembled measles (39) .
Although Korea experienced a series of resurgence of measles due to importation and healthcare-associated transmission in infants, the overall incidence and surveillance indicators met the WHO criteria for measles elimination. Following the Third Annual Meeting of the Regional Verification Commission for Measles Elimination in the Western Pacific Region in March 2014, Korea, Australia, Mongolia, and Macau China were verified to be measles-free for the first time since the criteria for measles- No. of cases 1 9 6 0 1 9 6 2 1 9 6 4 1 9 6 6 1 9 6 8 1 9 7 0 1 9 7 2 1 9 7 4 1 9 7 6 1 9 7 8 1 9 8 0 1 9 8 2 1 9 8 4 1 9 8 6 1 9 8 8 1 9 9 0 1 9 9 2 1 9 9 4 1 9 9 6 1 9 9 8 2 0 0 0 free verification were established in the region. One of the keys to effectively control measles in Korea was the establishment of routine immunization of 2 dose before entrance to elementary school. As the population immunity reaches threshold to interrupt measles transmission among traditionally high risk group for measles infection, there are eventual shift in age from pre-school aged children to school aged children (40, 41) . Targeting school-aged children for school-based mass vaccination campaign therefore is a rational approach for attaining adequate population immunity and to interrupt measles transmission in high risk population. Moreover, a policy requiring measles vaccination certificate when entering schools have been successful in ensuring high vaccination coverage rate (42) . The policy was also effective in decreasing measles incidence as observed in the United States, where the measles incidence was lower in states that had mandatory requirements for MCV2 at school entrance (43) .
FUTURE PERSPECTIVES
As the smallpox was eradicated globally in 1980, marking the first time that humans have removed an infectious disease, this triumph should be replicated in the case of measles and other vaccine-preventable diseases. Yet, evaluation of the ongoing resurgence of measles in the Korea has been helpful in understanding the reasons for continued disease occurrence in the countries and areas of WPR. Reports from most outbreaks were caused by non-vaccinated or under-vaccinated population, importation, and weak surveillance system. The continued occurrence of measles demonstrates that the virus continues to circulate around the globe, albeit at low levels of incidence in the Regions of America and Korea. The recent adoption of two-dose vaccination strategy by China and Japan may contribute to the dramatic reduction of measles cases in the WPR. Because not all countries in the WPR have solid health infrastructure and system, continuous supplementary vaccination activities including keep-up, follow-up, and mop-up strategies would be necessary. Full investigation of remaining measles cases, including confirmation of genotypes and documentation of epidemiological assessment, would provide additional opportunities for prevention. At present, most cases of measles in the WPR occur in preschool-aged children and in unvaccinated or partially vaccinated children aged 1-2 yr old. These observations reinforce the need to ensure universal and timely vaccination against measles in the WPR, and sharing the experiences from Korea would be helpful to other member states and areas.
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